J.M. Ashley et al. / Inorganica Chimica Acta 380 (2012) 399–410
407
for C41H61Cl2Ir2N5: C, 46.64; H, 5.92; N, 6.32. Found: C, 46.39; H,
5.75; N, 6.04%.
m/z = (M+H) 1148.3241 (1148.3369). Anal. Calc. for C47H57Cl2Ir2N5:
C, 46.63; H, 4.77; N, 5.67. Found: C, 46.30; H, 5.01; N, 6.11%.
4.3.13. (COD)ClIr{BnCPrN(Bn)PrCBn}IrCl(COD) (6c)
4.3.10. (COD)ClIr{MeBzCEtN(Bn)EtCBzMe}IrCl(COD) (5d)
Yield: 55 mg, 64%. 1H NMR (500 MHz, CDCl3): 1.45–1.71 (8H, m,
COD CH2), 1.90–2.30 (12H, m, COD CH2 and NCH2CH2CH2N), 2.62
(4H, m, CH2CH2CH2NBn), 2.90 (4H, m, COD CH), 3.65 (2H, m,
NCH2Ar), 4.16 (2H, m, COD CH), 4.50–4.65 (6H, m, COD CH and
Yield: 57 mg, 69%. X-ray quality crystals were grown by slow
evaporation from an acetone/pentane (30:70 v/v) solution.
1H NMR (500 MHz, CDCl3): 1.74 (6H, m, COD CH2), 2.03 (2H, m,
COD CH2), 2.14 (2H, m, COD CH2), 2.28 (4H, m, COD CH2), 2.85 (1H,
m, COD CH2), 2.89 (1H, m, COD CH2), 3.07 (4H, m, COD CH), 3.19
(2H, m, CH2CH2NBn), 3.48 (2H, m, CH2CH2NBn), 4.15 (5H, m and br
s, NCNCH3 and NCH2Ar), 4.15 (3H, s, NCNCH3), 4.51–4.71 (5H, m,
COD CH and NCNCH2CH2), 4.76 (1H, m, NCNCH2CH2), 5.11 (2H, m,
NCNCH2CH2), 7.12–7.52 (13H, m, Ar). 13C{1H} NMR (126 MHz,
CDCl3): 29.0, 29.2, 30.0, 30.4, 31.7, 33.1, 33.2, 34.2, 34.3, 34.4, 46.0,
46.5, 52.1, 52.3, 53.1, 53.1, 53.2, 53.7, 59.4, 60.7, 86.4, 86.6, 87.1,
87.2, 109.5, 109.5, 110.4, 110.5, 122.5, 122.6, 122.8, 122.8, 127.4,
127.5, 128.5, 128.7, 129.3, 129.4, 134.8, 135.0, 135.4, 135.5, 191.7,
191.8. HT FT–ICR MS: Found (Calc. for C43H53Cl2Ir2N5) m/z (M+H)
1096.2914 (1095.2937). Anal. Calc. for C43H53Cl2Ir2N5: C, 47.15; H,
4.88; N 6.39. Found: C, 47.41; H, 4.93; N 6.22%.
3
NCNCH2CH2CH2), 5.53 (1H, d, NCNCH2Ar, JH–H = 1.8), 5.53 (1H, d,
3
3
NCNCH2Ar, JH–H = 1.8), 5.68 (1H, d, NCNCH2Ar, JH–H = 7.3), 5.71
3
3
(1H, d, NCNCH2Ar, JH–H = 7.3), 6.59 (1H, d, HC@CH, JH–H = 2.0),
3
3
6.61 (1H, d, HC@CH, JH–H = 2.0), 6.80 (1H, d, HC@CH, JH–H = 2.0),
3
6.81 (1H, d, HC@CH, JH–H = 2.0), 7.20–7.40 (15H, m, C6H5).
13C{1H} NMR (126 MHz, CDCl3): 28.6, 28.8, 29.7, 29.8, 29.8, 33.7,
33.8, 33.8, 33.9, 49.1, 49.2, 50.8, 50.9, 51.9, 51.9, 52.1, 52.2, 54.5,
58.9, 58.9, 84.4, 84.5, 84.7, 84.7, 120.2, 121.2, 121.3, 127.2, 128.3,
128.4, 128.4, 128.5, 129.1, 129.2, 129.3, 136.7, 139.9, 140.0,
180.4, 180.5. HR FT-ICR MS: Found (Calc. for C49H61Cl2Ir2N5): m/
z = (M+H) 1176.3613 (1176.3641). Anal. Calc. for C49H61Cl2Ir2N5:
C, 49.78; H, 5.09; N, 5.91. Found: C, 50.05; H, 5.23; N, 5.96%.
4.3.14. (COD)ClIr{MeBzCPrN(Bn)PrCBzMe}IrCl(COD) (6d)
Yield = 36 mg, 71%. X-ray quality crystals were grown by slow
evaporation from an ethyl acetate/pentane (60:40 v/v) solution.
1H NMR (500 MHz, CDCl3): 1.67 (4H, m, COD CH2), 1.79 (4H, m,
COD CH2), 2.04 (2H, m, CH2CH2CH2), 2.24 (8H br m, COD CH2), 2.40
(2H, m, CH2CH2CH2), 2.78 (4H, br m, CH2CH2CH2NBn), 2.90 (2H, m,
COD CH), 3.00 (2H, m, COD CH), 3.75 (2H, see axial chirality section,
NCH2Ar), 4.17 (3H, s, NCH3), 4.17 (3H, s, NCH3), 4.43 (2H, m, NCNCH2
CH2CH2), 4.71 (4H, m, COD CH), 4.98 (2H, m, NCNCH2 CH2CH2), 7.16–
7.51 (13H, m, Ar). R,R-(COD)ClIr{MeBzCPrN(Bn)PrCBzMe}IrCl(COD)
13C{1H} NMR (126 MHz, CDCl3): 26.2, 29.4, 29.8, 33.5, 34.0, 34.5,
46.7, 50.1, 52.4, 52.7, 58.5, 86.5, 86.6, 109.6, 110.4, 122.5, 127.0,
128.4, 129.2, 134.8, 135.7, 140.1, 191.5 R,S-(COD)ClIr{MeBzCPrN(Bn)Pr
CBzMe}IrCl(COD) 13C{1H} NMR (126 MHz, CDCl3): 27.1, 29.2, 30.0,
33.3, 34.1, 34.5, 46.8, 51.0, 52.2, 52.9, 58.5, 86.4, 86.9, 109.6, 110.4,
122.6, 122.7, 127.1, 128.4, 129.2, 134.7, 139.7, 139.8, 191.6. HR FT
ICR MS Found: (Calc. for C45H57Cl2Ir2N5) m/z 1123.3315 (1123.32
50). Anal. Calc. for C45H57Cl2Ir2N5: C, 48.12; H, 5.11; N, 6.23. Found:
C, 47.35; H, 4.96; N, 5.92%.
4.3.11. (COD)ClIr{MeCPrN(Bn)PrCMe}IrCl(COD) (6a)
The following representative procedure was used for the syn-
thesis of 6a–6d:
[Ir(COD)Cl]2 (108 mg, 0.160 mmol) and [(MeCPrN(Bn)PrCMe)Ag]Á
[AgCl2] (4a) (100 mg, 0.160 mmol) were dissolved in dichlorometh-
ane (10 mL). The reaction was stirred for 3 h and then the solution
was filtered through Celite. The solvent was removed under reduced
pressure and the yellow solid washed with pentane (2 Â 2 mL). The
precipitate was collected as a yellow crystalline solid. The solid was
purified using column chromatography (acetone/hexane (30:70 v/
v)). Yield: 95 mg, 58%.
1H NMR (500 MHz, CD2Cl2): 1.45–1.75 (10H, br m, COD CH2 and
NCH2CH2CH2N), 1.96 (2H, m, NCH2CH2CH2N), 2.17 (8H, br m, COD
CH2), 2.59 (4H, m, CH2CH2CH2NBn), 2.88 (2H, br, COD CH), 2.96
(2H, br, COD CH), 3.65 (2H, m, NCH2Ar), 3.91 (6H, s, NCH3), 4.14
(2H, m, COD CH), 4.45 (4H, br, NCNCH2CH2CH2), 4.54 (2H, m,
COD CH), 6.81 (2H, br, HC@CH), 6.85 (2H, m, HC@CH), 7.25 (1H,
3
t, para-C6H5, JH–H = 7.4), 7.33 (2H, m, meta-C6H5), 7.41 (2H, m
ortho-C6H5). 13C{1H} NMR (126 MHz, CDCl3): 28.6, 28.8, 29.5,
29.6, 30.0, 30.1, 33.5, 33.6, 34.0, 34.1, 37.6, 49.0, 49.0, 51.4, 51.5,
51.9, 51.9, 58.8, 84.1, 84.2, 84.2, 84.3, 120.8, 120.8, 121.7, 121.7,
127.1, 128.5, 129.3, 129.3, 139.9, 140.0, 180.1, 180.2. HR FT–ICR
MS: Found (Calc. for C37H53Cl2Ir2N5): m/z = (M+H) 1024.2986
(1024.3015). Anal. Calc. for C37H53Cl2Ir2N5: C, 42.15; H, 4.88; N,
6.38. Found: C, 42.70; H, 5.22; N, 6.85%.
4.3.15. (COD)ClRh{MeCPrN(Bn)PrCMe}RhCl(COD) (7a)
The following representative procedure was used for the syn-
thesis of 7a, 7c and 7d:
[Rh(COD)Cl]2 (50 mg, 0.101 mmol) and [(MeCPrN(Bn)PrCMe)Ag]Á
[AgCl2] (3a) (63 mg, 0.101 mmol) were dissolved in dichlorometh-
ane (10 ml) and the reaction mixture stirred for 1 h. The yellow solu-
tion was filtered through Celite and the filtrate collected. The solvent
was removed under reduced pressure and the resulting solid
washed with pentane (2 Â 10 mL) to give 7a as a yellow crystalline
solid. The solid was purified using column chromatography
(acetone/hexane (30:70 v/v)). Yield: 83 mg, 95%.
4.3.12. (COD)ClIr{tBuCPrN(Bn)PrCtBu}IrCl(COD) (6b)
This reaction was performed in toluene instead of dichloro-
methane. Yield: 38 mg, 38%.
1H NMR (400 MHz, CDCl3): 1.47 (4H, m, COD CH2), 1.61 (4H, m,
COD CH2), 1.84 (18H, s, NCCH3), 1.92 (4H, m, COD CH2 and
CH2CH2CH2), 2.12 (6H, m, COD CH2), 2.30 (2H, m, CH2CH2CH2),
2.61 (4H, CH2CH2CH2NBn), 2.71 (2H, m, COD CH), 2.79 (2H, m,
COD CH), 3.64 (2H, m, NCH2Ar), 4.27 (2H, m, NCNCH2CH2CH2),
4.45 (2H, m, COD CH), 4.52 (2H, m, COD CH), 5.12 (2H, m,
1H NMR (500 MHz, CDCl3): 1.85 (8H, br m, COD CH2), 1.98 (2H,
m, NCH2CH2CH2N), 2.24 (8H, br m, COD CH2), 2.38 (2H, m,
NCH2CH2CH2N), 2.60 (4H, m, CH2CH2CH2NBn), 3.14 (2H, br, COD
CH), 3.23 (2H, br, COD CH), 3.63 (2H, m, NCH2Ar), 3.98 (6H, s,
NCH3), 4.15 (2H, m, COD CH), 4.67 (2H, m, COD CH), 4.90 (4H, br,
NCNCH2CH2CH2), 6.69 (2H, br, HC@CH), 6.75 (1H, d, HC@CH,
2
3
NCNCH2CH2CH2), 6.87 (1H, d, HC@CH, JH–H = 2.1), 6.93 (1H, d,
3JH–H = 1.8), 6.76 (1H, d, HC@CH, JH–H = 1.8), 7.18 (1H, m, para-
2
2
HC@CH, JH–H = 2.1), 6.97 (1H, d, HC@CH, JHÀH = 2.1), 6.98 (1H, d,
C6H5), 7.27 (2H, m, meta-C6H5), 7.37 (2H, m ortho-C6H5). 13C{1H}
NMR (126 MHz, CDCl3): 28.6, 28.8, 28.8, 28.8, 29.3, 29.3, 32.8,
32.8, 33.4, 33.4, 37.9, 49.2, 49.2, 50.7, 50.9, 58.8, 67.6 (d,
HC = CH, JH–H = 2.1), 7.23–7.39 (5H, m, C6H5). 13C{1H} NMR
2
(101 MHz, CDCl3): 28.1, 28.6, 29.5, 29.5, 29.6, 29.7, 32.8, 33.0,
33.2, 33.6, 33.8, 50.4, 50.7, 51.1, 51.2, 51.2, 51.2, 53.3, 52.4, 58.7,
58.9, 59.0, 79.2, 79.4, 81.6, 81.7, 119.5, 119.5, 120.2, 127.0, 128.3,
129.2, 129.2, 139.8, 140.0, 178.9, 179.0. HT FT-ICR MS: Found (Calc.
for C41H61Cl2Ir2N5) m/z (M+H) 1108.3924 (1107.3876). Anal. Calc.
1
1
1JRh-C = 7.6), 67.8 (d, JRh-C = 7.6), 68.3 (d, JRh-C = 14.5), 98.2 (m),
121.0, 121.1, 122.0, 127.1, 128.4, 129.2, 129.3, 139.9, 140.0, 181.8
1
1
(d, JRh-C = 16.1), 182.2 (d, JRh-C = 16.3). HR FT-ICR MS: Found
(calcd for C37H53Cl2N5Rh2): m/z = (M-Cl) 808.2083 (808.2100).